ELEVANCE HEALTH Aktie

 

Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....

Live Updates Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now. Insider Buying: Elevance Health CEO Buys After Post-Earnings Drop 4 minutes ago Live Elevance Health's (NYSE: ELV) CEO Gail Boudreaux picked up 2,725 shares of the stock for $1 million just days ... Stock Market Live July 28, 2028: S&P 500 (SPY) Struggling to Stay Green...

Peru's $366,050 purchase expands his direct stake to 10,908 shares, now valued at $4.03 million following the stock's 22% one-year gain....

Peru, Ramiro G. - Aufsichtsrat - Tag der Transaktion: 2026-07-17...

Boudreaux, Gail - Vorstand - Tag der Transaktion: 2026-07-17...

Boudreaux's stake now totals ~172,000 directly held shares worth $63.51 million, as Elevance maintains an $80 billion market cap and $5.0 billion in trailing net income....

CEO Boudreaux raised full-year guidance after beating Q2 projections....

Elevance Health beats Q2 EPS and revenue estimates, raises 2026 adjusted EPS outlook despite lower earnings, softer membership and higher expenses....

The headline numbers for Elevance Health (ELV) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....

Elevance Health (ELV) delivered earnings and revenue surprises of +20.55% and +2.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?...

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

The health insurer raised its earnings outlook after logging a higher benefit-expense ratio and sales number in the second quarter....

WASHINGTON (dpa-AFX) - Elevance Health (ELV) said second quarter results exceeded its outlook. The company increased 2026 EPS guidance to at least $20.10, and lifted 2026 adjusted EPS guidance to ......

WASHINGTON (dpa-AFX) - Elevance Health Inc. (ELV) reported a profit for second quarter that Drops, from last yearThe company's earnings came in at $1.463 billion, or $6.71 per share. This compares......

Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

2Q 2026 operating revenue of $49.8 billion, up 0.8% from 2Q 2025 2Q 2026 diluted EPS1 of $6.71 and adjusted diluted EPS2 of $7.45; results were supported by favorable benefit expense performance and an approximately $0.80 per share net below-the-line benefit FY 2026 diluted EPS1 guidance raised to at least $20.10; adjusted diluted EPS2 guidance raised to at least $27.00, reflecting strong second quarter operating results Accelerating targeted investments in capabilities that lower healthcare costs, simplify the member and provider experience, and strengthen Carelon's integrated solutions FY 2026 operating cash flow guidance raised to at least $6.0 billion INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported second quarter 2026 results ahead of expectations. "Our second quarter results exceeded our outlook, supported by disciplined execution and improved operating performance across our diversified portfolio. We are raising our 2026 adjusted EPS guidance to at least $27.00 and ac...